Maestro

Moon Surgical's Maestro is a laparoscopic surgical-assistant platform (it holds and positions instruments and the endoscope alongside the surgeon, not a full master-slave teleoperated replacement system) and the assistive-laparoscopy archetype of DEPLOY's surgical cluster, editorially distinct from the replacement-robotics of Intuitive, Medtronic, and CMR. Its ScoPilot software is shipped AI (NVIDIA Holoscan-powered) for intraoperative scope control. On regulatory status (a correction worth recording): the Maestro received FDA 510(k) clearance K240598 on June 5, 2024 (not December 2023), and ScoPilot was FDA-cleared in 2025 with a Predetermined Change Control Plan. As enterprise B2B surgical equipment, there is no consumer price.

Readiness

Maestro is internal use only (not for retail) at $300,000-$800,000 (analyst estimate), the 1 capability claim on file is all teleoperated-assisted with verified, 1 verified deployment is on file, and no incidents are on record.

Availability

internal-only

Internal use only (not for retail).

see evidence →

Price honesty

analyst-estimate

One price on file: $300,000-$800,000 (analyst estimate).

see evidence →

Capability honesty

teleoperated-assisted

1 reviewed claim: teleoperated-assisted, verified.

see evidence →

Real-world use

pilot

Maturity: pilot. 1 verified deployment in the registry.

see evidence →

Safety record

no-incidents

No incidents on record. 1 verified deployment on file.

What it claims to do

• Assists surgeryteleoperated-assisted· verifiedevidence ↗

Price

• $300,000-$800,000analyst estimate · How Much is a Surgical Robot? (2025 Edition) – R2 Surgical ↗ · as of 2025-01-01

Real-world use

• Jacksonville operated by Moon Surgical2023-09-26

Safety record

No incidents on record. 1 verified deployment on file.

Privacy

No privacy practices disclosed or on file for Maestro.

Specs

notes

• Verified: Moon Surgical (private; Paris + San Carlos CA; CEO Anne Osdoit; board chair Fred Moll, Intuitive co-founder; backers Sofinnova + NVentures/NVIDIA) makes Maestro, a laparoscopic surgical-ASSISTANT/collaboration robot (holds/positions instruments alongside the surgeon, not a full teleop console). Commercial Maestro FDA 510(k)-cleared Jun 5 2024 (K240598); >1,100 patients treated across US + Europe (company-stated). ~$90M+ raised.
• AI-substance: genuine SHIPPED AI (notable): ScoPilot is a genuine SHIPPED, FDA-cleared AI feature (intraoperative scope control via NVIDIA Holoscan), with a PCCP - not merely demonstrated. This distinguishes Maestro from the teleop-only platforms in this cohort. Maestro itself is a collaborative/assist robot (an honest distinction from full master-slave teleop).
• CORRECTION (pathway): Maestro went the 510(k) route (K240598), NOT de novo (the dispatch hypothesized de novo). De novo around that time was Virtual Incision/MIRA and MMI/Symani - different companies.
• Claimed but NOT verified: CE mark status/date (unverified this pass); exact installed-system count; the 'industry's first AI on a commercial surgical robot' superlative (marketing); the >1,100-patients figure (company-sourced).

console

not a full master-slave teleoperation console

products

Maestro: a laparoscopic surgical-assistant platform (holds/positions instruments + endoscope alongside the surgeon). ScoPilot: shipped AI software (NVIDIA Holoscan-powered) for intraoperative scope control. Commercial Maestro FDA 510(k) K240598 cleared Jun 5 2024; ScoPilot FDA-cleared 2025 with a Predetermined Change Control Plan (PCCP).

formFactor

surgical (laparoscopic surgical-assistant / collaboration robot: holds + positions instruments alongside the surgeon; not full master-slave teleop)

fda_clearance

FDA 510(k) clearance under K240598 on June 5, 2024

clearance_body

FDA

procedure_types

laparoscopic

What's under the hood

No brain on file for Maestro.

Frequently asked questions

Video

Compare side by side

• Maestro vs Hugo RASby Medtronic · surgical

Sources

1. Moon Surgical: 2nd FDA clearance covering the commercial Maestro system (Jun 2024) · https://www.prnewswire.com/news-releases/moon-surgical-second-fda-clearance-commercial-maestro ↗
2. FDA 510(k) K240598: Maestro System (cleared Jun 5 2024) · https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K240598 ↗
3. Moon Surgical ScoPilot AI FDA clearance (with PCCP; NVIDIA Holoscan) · https://www.biospace.com/moon-surgical-scopilot-fda-nvidia-holoscan ↗
4. Moon Surgical raises $55.4M; Fred Moll board chair; NVentures-backed · https://www.massdevice.com/moon-surgical-funding-fred-moll/ ↗
5. Moon Surgical receives second FDA clearance, covering its commercial Maestro Robotic Surgery System -- PR Newswire, June 2024; FDA 510(k) cleared for commercial version; CE marked September 2023; 200+ patients treated at European pilot sites · https://www.prnewswire.com/news-releases/moon-surgical-receives-second-fda-clearance-covering-its-commercial-maestro-robotic-surgery-system-302164186.html ↗ · 2024-06-05
6. Moon Surgical official YouTube (@moonsurgical), embedded under standard YouTube embed terms. oEmbed author_url verified 2026-06-04. Maker product video; surgeon-teleoperated/assisted system, not autonomous. · https://www.youtube.com/watch?v=AuplMN-VpCU ↗ · 2026-06-04
7. How Much is a Surgical Robot? (2025 Edition) – R2 Surgical · https://r2surgical.com/blogs/news/how-much-is-a-surgical-robot-2025-edition ↗
8. Moon Surgical Announces First Clinical Cases in the U.S. Using Maestro System · https://www.businesswire.com/news/home/20230926938682/en/Moon-Surgical-Announces-First-Clinical-Cases-in-the-U.S.-Using-Maestro-System ↗ · 2023-09-26
9. First U.S. clinical cases performed with Moon Surgical's Maestro surgical robot · https://www.massdevice.com/first-cases-moon-surgical-maestro-surgical-robot/ ↗ · 2023-09-26

Ask the registry